Auren Rx Microdose Review: $149 Semaglutide, $250 Tirzepatide

Most telehealth companies that mention microdosing mention it. Auren Rx sells it: a program with its own page, its own slug, its own intake and its own price table across both molecules. We checked the site in August 2026. On the one question this site exists to ask a provider — do you charge me less when I take less? — Auren Rx gives the clearest yes of any company we have looked at recently. It also declines to answer a question every one of its competitors answers, and that omission is the reason this is not a straightforward recommendation.

This is an editorial review. Auren Rx is not a partner of ours, there is no affiliate link on this page, and nothing about it is ranked on our GLP-1 microdose rankings hub.

The four rungs

Auren Rx publishes two prices for every product it sells: a discounted subscription rate and an explicit "monthly — no commitment" rate, side by side on the same page. Across the GLP-1 line that produces four rungs.

We file the month-to-month figures throughout — $199 and $299 standard, $149 and $250 microdose — because that is what you pay if you decline to commit, and because the site's own structured data will hand you the other set. Its Product markup emits the subscribe rung, so anything reading the machine-readable page rather than the rendered one records $169 and $259 as "the Auren Rx price". Both are real numbers. Only one of them is the price of being able to stop.¹

Does the microdose actually cost less?

Yes, and by a margin large enough to be worth naming. Month-to-month, microdose semaglutide is $50 a month below the standard semaglutide plan — $600 over a year, a quarter off the standard rate. Microdose tirzepatide is $49 a month below standard tirzepatide, $588 over a year, about 16% off. On a subscription the gaps narrow to $40 and $30 but do not close.

That sounds obvious. It is not. The premise of a microdose program is that you are buying less drug, and a great many companies that sell one charge you exactly what they charge everyone else — the structure we take apart in what microdosing GLP-1 costs and rank against directly on the cheapest semaglutide for microdosing. Some price the low-dose line above their own standard product. Auren Rx does neither. Its microdose rung is a genuine discount on its own standard rung, on both molecules, at both commitment levels.

Three ways to write down the wrong number

The clean ladder is undermined by three capture traps, and all three of them run through the microdose program.

The selector defaults to tirzepatide. The weight-loss page loads with tirzepatide already chosen. Open it, glance at the price, and you have filed $299 as "Auren Rx" when semaglutide is $199. This is the single most common way a provider price gets recorded wrong anywhere on the internet, and it is live on this site.

The structured data quotes the subscribe rung. Covered above. If you see Auren Rx quoted at $169 somewhere, this is why.

The navigation quotes the microdose price under a standard-GLP-1 heading. The nav reads "Semaglutide & Tirzepatide from $129/mo". $129 is the microdose semaglutide subscribe rung. The cheapest standard GLP-1 rung is $169 subscribed and $199 monthly, so the heading understates standard GLP-1 by $70 a month. Nothing here is invented — $129 is a real, purchasable price — but the microdose program's cheapest number is doing promotional work for the standard product, which is the inverse of what a microdose shopper needs. Read the program page, not the menu.

What Auren Rx will not tell you

It never publishes the states it serves. Its terms refer to "certain states" and to "a State Where We Operate" and then list none, anywhere on the site. Every other provider in the batch this review came from either publishes a list or claims all fifty. This is the largest hole in an otherwise strong disclosure record, and it is worst for exactly the readers who most need to know: if you live somewhere with restrictive telehealth rules, you will not find out whether you qualify until you are inside an intake.

The pharmacy is never named individually — described as "Auren RX or one of our partner pharmacies". You may instead elect a local pharmacy of your choice, in which case the membership fee excludes the medication cost, which is a real and unusual option. Still, an unnamed pharmacy fails the second item on our provider trust checklist, and it matters more than usual for compounded product you will be measuring yourself.

No individual prescriber is named and no NPI is published. Clinical services are attributed to Beluga Health, P.A., a real telehealth professional association. The corporate entity is Hades Capital LLC, doing business as Auren RX, with no address published.

Fees, cadence and getting out

The membership fee is charged the day membership commences and is non-refundable once paid. Membership begins after a provider communicates a care plan and you elect to proceed — so the charge follows clinical review rather than preceding it, which is better than several companies in this market and worth crediting. Billing then runs approximately every 28 to 30 days, which is slightly short of a calendar month and is disclosed as such. Cancellation is month-to-month by email or in-account, and membership can be paused with no further charges until you order a refill, which is the right shape for someone holding a low dose and stretching a vial.

There is no prepay tier at all, so there is no prepay rate masquerading as a monthly one — the trap that turns up constantly on the cheapest-looking rows in this market.

The regulatory screen

The trading name, the legal entity, the medical group and the platform vendor each returned zero company-column matches in the FDA's live warning-letter index in August 2026.² That screen carried a positive control — an unrelated telehealth seller with a real 2026 letter — which returned correctly on every pass, so the zeros are evidence rather than a query that quietly stopped working.

The thing a good program cannot fix

None of the above changes the fact underneath it. No randomized controlled trial has tested below-label GLP-1 dosing — not for weight, not for glycemic control, not for safety. The only clinical literature that addresses microdosing directly does so as a caution, describing a practice that emerged amid compounding restrictions and built on patient anecdote rather than tested protocol.³ A named program, a four-rung table and a pause button make Auren Rx an unusually well-organized way to buy an untested practice. They do not make the practice tested, and a company that builds a clean checkout around a gap in the evidence has not narrowed the gap. We lay out what is and is not known in is microdosing GLP-1 legit or hype and does microdosing GLP-1 work.

The honest bottom line

On pricing structure, Auren Rx is the best-built surface we have read this year: a no-commitment rung beside every subscribe rung, a microdose line that is genuinely cheaper than its own standard line on both molecules, a correctly labeled billing cadence and no prepay tier to hide anything in. On disclosure it has one specific, avoidable failure — you cannot learn whether it serves your state without starting an intake — plus an unnamed pharmacy and no verifiable prescriber. Weigh those against each other rather than averaging them. For contrast on the same question, Vyvron prices its microdosing program below its weight-loss program too, and then bills it every four weeks, while Pepti charges more for the SKU it labels a microdose than for the molecule on its own.